Prof Dan Siskind is clinical academic psychiatrist in Brisbane, Australia who works with people with treatment refractory schizophrenia. His research interests include treatment refractory schizophrenia, clozapine and the cardiometabolic comorbidities of schizophrenia.
He has over 190 publications and over AU$35million in competitive research grants.
Sign up for our newsletter to get the latest AEPCC news straight to your inbox.